Portal
Zhihui Song is currently working as a Senior Scientist at Portal since 2023. Prior to this, Zhihui Song worked at Fox Chase Cancer Center from November 2016 to May 2023, initially starting as a Scientific Researcher and then becoming a Postdoctoral Associate. Zhihui Song obtained a Doctor of Philosophy - PhD from the Institute of Zoology, Chinese Academy of Sciences in 2016, after completing a Bachelor's degree from Tianjin University.
This person is not in any teams
Portal
Portal is a cell engineering platform company focused on enabling next generation cell engineering and cell analytics across research and clinical applications. We are implementing a simplified approach to intracellular delivery, focused on accelerating advances enabled by the new generation of RNA, gene editing, and AI-driven technologies. Portal’s initial product suite is based on a proprietary mechanical delivery system capable of delivering many different types of cargo to a broad range of cell types. The technology's ability to be used stand-alone or as an integrated component of third-party systems provides a significant opportunity to broadly impact the fields of biological research and cellular therapeutics